Evaluation of clopidogrel impact on canine platelet function using flow cytometry and thromboelastography platelet mapping

Evaluation of clopidogrel impact on canine platelet function using flow cytometry and thromboelastography platelet mapping

BackgroundClopidogrel is frequently used in veterinary medicine to therapeutically decrease platelet function, although some different dosages have been published. Therefore, we assessed the antiplatelet effects of the recommended dosage (1 mg/kg PO q24h) on canine platelet function.MethodsFive dogs...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eunchae Yoon, Chaewon Shin, Hyeona Bae, Kyu-Woan Cho, Dong-In Jung, Jinho Park, Dongbin Lee, DoHyeon Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Veterinary Science
Subjects:	clopidogrel flow cytometry platelet aggregation thromboelastography adenosine diphosphate
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2025.1555641/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RESIDUAL PLATELET REACTIVITY TO ADP AND THE RISK OF BLEEDING IN STABLE CHD PATIENTS RECEIVING DOUBLE ANTIPLATELET THERAPY FOR ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: E. V. Guskova, et al.
Published: (2015-03-01)

Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses
by: Guk-Il Joung, et al.
Published: (2024-12-01)

Evaluating platelet concentrates by platelet indices, thromboelastography, and flow cytometry
by: Tapasyapreeti Mukhopadhyay, et al.
Published: (2024-12-01)

Comprehensive evaluation of coagulability using thromboelastography in four patients with essential thrombocythemia
by: Shuji Kawamoto, et al.
Published: (2025-05-01)

Application of the rotational thromboelastography/thromboelastometry for assessment of massive obstetric blood loss in a high risk group
by: D. R. Eremeeva, et al.
Published: (2020-04-01)

The results of hemostasis assessment using thromboelastography in patients with COVID-19
by: V. N. Gorodin, et al.
Published: (2023-10-01)

COMPARISON OF THE ORIGINAL (PLAVIx) AND GENERIC (CLAPITAx) CLOPIDOGREL ON PLATELET AGGREGATION: ObSERVATIONAL STUDY
by: A. S. Skotnikov, et al.
Published: (2018-05-01)

Comparison of Fibrinolysis in Peripartum and Non-Pregnant Mares Using Modified Thromboelastography
by: Kira L. Epstein, et al.
Published: (2025-06-01)

Combined role of thromboelastography and coagulation indicators in predicting thromboembolism risk in cancer patients
by: Liqiu Huang, et al.
Published: (2025-08-01)

Thromboelastography parameters in chronic viral liver disease and liver resection: a retrospective study
by: Ying Di, et al.
Published: (2024-08-01)

CORRELATION BETWEEN TIME TO HOSPITALIZATION AND THROMBOELASTOGRAPHY PARAMETERS IN PATIENTS WITH SPLENIC INJURIES IN THE EARLY POSTOPERATIVE PERIOD
by: V. V. Maslyakov, et al.
Published: (2021-02-01)

Evaluation of clopidogrel responsiveness using the Platelet Function Analyzer-200 (PFA-200) in dogs
by: Joon-Ho Shin, et al.
Published: (2025-07-01)

Thromboelastography-based dynamic evaluation of perioperative coagulation changes and anticoagulant efficacy in lung cancer patients
by: Songping Cui, et al.
Published: (2025-04-01)

The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer
by: Wenqin Ren, et al.
Published: (2024-12-01)

Natural pentafuranosylnucleos(t)ides and their analogs: structure, functions, synthesis, and perspective of medical application
by: Dmitrii Platov, et al.
Published: (2025-05-01)

Comparative bioavailability of two oral formulations of clopidogrel: Determination of clopidogrel and its carboxylic acid metabolite (SR26334) under fasting and fed conditions in healthy subjects
by: Brvar Nina, et al.
Published: (2014-03-01)

Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia
by: Chih-Lung Shen, et al.
Published: (2022-01-01)

Upfront maintenance poly(Adenosine Diphosphate Ribose) polymerase inhibitors in ovarian cancer: A ray of hope or just a mirage!
by: Avinash Pandey, et al.
Published: (2020-01-01)

Hemostatic conditions following autologous transfusion of fresh vs stored platelets in experimental endotoxemia: an open-label randomized controlled trial with healthy volunteers
by: Stefan F. van Wonderen, et al.
Published: (2024-11-01)

Flow cytometry immunophenotyping of healthy platelets and hospitalized patients with suspected platelet dysfunction: Challenges for establishing a cutoff value
by: Daiane Keller Cecconello, et al.
Published: (2024-11-01)

Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia
by: Veronika Dill, et al.
Published: (2024-12-01)

EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

Thromboelastography for the evaluation of coagulation function in patients with hepatic echinococcosis during the perioperative period: a retrospective study
by: Xing Zheng, et al.
Published: (2025-08-01)

Clopidogrel therapy in acute coronary syndrome: Contemporary issues
by: Satyavir Yadav, et al.
Published: (2025-07-01)

THE MODERN ASPECTS OF CLOPIDOGREL USE
by: E. N. Dankovtseva, et al.
Published: (2016-01-01)

The study of structural-mechanical characteristics of suppositories with clopidogrel
by: Ye. А. Redkina, et al.
Published: (2018-10-01)

Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography
by: Hyun-Jung Shin, et al.
Published: (2025-04-01)

Clopidogrel in cardiovascular disease treatment: modern clinical recommendations
by: I. S. Yavelov
Published: (2006-10-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Real-time platelet P2Y12 receptor occupancy as a promising pharmacodynamics biomarker for bridging the gap between PK/PD of clopidogrel therapy
by: Haipeng Li, et al.
Published: (2025-01-01)

Comparative study of specific activity of rectal suppositories with clopidogrel
by: I. L. Kechyn, et al.
Published: (2021-12-01)

Endobronchial biopsies in patients receiving clopidogrel and aspirin treatment
by: Bilal Rabahoğlu, et al.
Published: (2025-07-01)

ANTIPLATELET ACTIVITY OF ORIGINAL CLOPIDOGREL AND ITS GENERIC: RESULTS OF RANDOMIZED COMPARATIVE CROSS-OVER STUDY
by: V. V. Yakusevich, et al.
Published: (2014-07-01)

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
by: Lisa Daniel-Fischer, et al.
Published: (2024-02-01)

The study of excipients’ influence on Clopidogrel releasing from the rectal suppositories
by: Ye. А. Redkina, et al.
Published: (2018-03-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

ANTIAGGREGANT THERAPY AND REDUCTION OF HIGH RESIDUAL PLATELET REACTIVITY
by: N. A. Mazur, et al.
Published: (2012-08-01)

Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization
by: Min Lu, et al.
Published: (2025-01-01)

Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor?
by: Nil Ozyuncu, et al.
Published: (2020-07-01)

HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?
by: E. P. PANCHENKO
Published: (2017-12-01)